Drug Profile
Recombinant haemoglobin 1.1
Alternative Names: Human recombinant haemoglobin - Baxter Healthcare; Optro; Recombinant haemoglobin 1.1- Baxter Healthcare; Recombinant human haemoglobin - Somatogen; rHb 1.1Latest Information Update: 06 Dec 2001
Price :
$50
*
At a glance
- Originator Baxter Healthcare Corporation
- Class
- Mechanism of Action Oxygen carriers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hypovolaemia
Most Recent Events
- 06 Dec 2001 Discontinued-Clinical for Hypovolaemia in Canada (IV-infusion)
- 06 Dec 2001 Discontinued-Clinical for Hypovolaemia in USA (IV-infusion)
- 28 Jun 2001 No-Development-Reported for Hypovolaemia in Canada (IV-infusion)